Association between a CTGF gene polymorphism and systemic sclerosis in a French population

Journal of Rheumatology

Volumn 37, Issue 2, 2010, Pages 351-358

  Granel, Brigitte ^a   Argiro, Laurent ^a   Hachulla, Eric ^b   Fajardy, Isabelle ^b   Weiller, Pierre Jean ^c   Durand, Jean Marc ^d   Frances, Yves ^e   Dombey, Anne Marie ^f   Marquet, Sandrine ^a   Lesavre, Nathalie ^e   Disdier, Patrick ^c   Bernard, Fanny ^a   Hatron, Pierre Yves ^b   Chevillard, Christophe ^a  

^a INSERM   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c TIMONE HOSPITAL   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e HÔPITAL NORD   (France)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Connective tissue growth factor; Disease susceptibility; Electrophoretic mobility shift assay; Polymorphism; Scleroderma

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; FRANCE; GEL MOBILITY SHIFT ASSAY; GENOTYPE; HUMAN; HUMAN CELL; LIVER CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; UNIVARIATE ANALYSIS;

EID: 76649103349     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090290     Document Type: Article

References (23)

1. Kawakami T, Ihn H, Xu W, Smith E, LeRoy C, Trojanowska M. Increased expression of TGF-beta receptors by scleroderma fibroblasts: evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype. J Invest Dermatol 1998;110:47-51.
2. Ihn H, Yamane K, Kubo M, Tamaki K. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors. Arthritis Rheum 2001;44:474-80.
3. Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000;27:149-54.
4. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst GR, et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995;105:280-4.
5. Leask A, Denton CP, Abraham DJ. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma. J Invest Dermatol 2004;122:1-6.
6. Holmes A, Abraham DJ, Chen Y, Denton C, Shi-wen X, Black CM, et al. Constitutive connective tissue growth factor expression in scleroderma fibroblasts is dependent on Sp1. J Biol Chem 2003;278:41728-33.
7. Shi-wen X, Pennington D, Holmes A, Leask A, Bradham D, Beauchamp JR, et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 2000;259:213-24.
8. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 1999;181:153-9.
9. Takehara K. Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 2003;30:755-9.
10. Zhou X, Tan FK, Wang N, Xiong M, Maghidman S, Reveille JD, et al. Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence. Arthritis Rheum 2003;48:2585-92.
11. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, Holmes AM, et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007;357:1210-20.
12. Kawaguchi Y, Ota Y, Kawamoto M, Ito I, Tsuchiya N, Sugiura T, et al. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis 2008; 68:1921-4.
13. Gourh P, Mayes MD, Arnett FC. CTGF polymorphism associated with systemic sclerosis. N Engl J Med 2008;358:308-9; author reply 309.
14. Rueda B, Simeon C, Hesselstrand R, Herrick A, Worthington J, Ortego-Centeno N, et al. A large multicentre analysis of CTGF -945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype. Ann Rheum Dis 2009;68:1618-20.
15. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
16. Sambrook JE, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989:1.3-1.105.
17. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
18. Nyholt DR. Evaluation of Nyholt's procedure for multiple testing correction - author's reply. Hum Hered 2005;60:61-2.
19. Gruber AR, Lorenz R, Bernhart SH, Neubock R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res 2008;36:W70-4.
20. Conne B, Stutz A, Vassalli JD. The 3′ untranslated region of messenger RNA: A molecular 'hotspot' for pathology? Nat Med 2000;6:637-41.
21. Kubota S, Mukudai Y, Moritani NH, Nakao K, Kawata K, Takigawa M. Translational repression by the cis-acting element of structure-anchored repression (CAESAR) of human ctgf/ccn2 mRNA. FEBS Lett 2005;579:3751-8.
22. Kubota S, Kondo S, Eguchi T, Hattori T, Nakanishi T, Pomerantz RJ, et al. Identification of an RNA element that confers post-transcriptional repression of connective tissue growth factor/hypertrophic chondrocyte specific 24 (ctgf/hcs24) gene: similarities to retroviral RNA-protein interactions. Oncogene 2000;19:4773-86.
23. Ikawa Y, Ng PS, Endo K, Kondo M, Chujo S, Ishida W, et al. Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis. J Cell Physiol 2008;216:680-7.